Low-Dose and Limited-Volume Radiotherapy Alone for Primary Dural Marginal Zone Lymphoma: Treatment Approach and Review of Published Data

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 5, 2008, Pages 1425-1435

  Puri, Dev R ^a   Tereffe, Welela ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Dura; Involved field; Lymphoma; MALT; Marginal zone; Mucosa associated lymphoid tissue; Radiotherapy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; ELECTROTHERAPEUTICS; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; NEUROLOGY; RADIOTHERAPY; RESONANCE; TOMOGRAPHY;

CENTRAL NERVOUS SYSTEM; COMPUTED TOMOGRAPHY SCANS; DURA; IMMUNOPHENOTYPE; INVOLVED FIELD; LOCAL CONTROL; LOW-DOSE; LYMPHOMA; MALT; MARGINAL ZONE; MUCOSA-ASSOCIATED LYMPHOID TISSUE; NEUROTOXICITY; RADIOTHERAPY ALONE; SOFT TISSUES; TUMOR RESECTION; VOLUME DETERMINATION; VOLUME PARAMETERS;

IMAGING TECHNIQUES;

CYTARABINE; DOXORUBICIN; FLUDARABINE; FOLINIC ACID; GADOLINIUM; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MONOTHERAPY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIMARY DURAL LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; SEPSIS; TREATMENT OUTCOME;

ADULT; BRAIN NEOPLASMS; DURA MATER; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47149114533     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.12.007     Document Type: Article

References (43)

1. DeAngelis L.M., Seiferheld W., Schold S.C., et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10. J Clin Oncol 20 (2002) 4643-4648
2. Omuro A.M., Ben-Porat L.S., Panageas K.S., et al. Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62 (2005) 1595-1600
3. Omuro A.M., DeAngelis L.M., Yahalom J., et al. Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-up. Neurology 64 (2005) 69-74
4. Bertoni F., and Zucca E. State-of-the-art therapeutics: Marginal-zone lymphoma. J Clin Oncol 23 (2005) 6415-6420
5. Kumar S., Kumar D., Kaldjian E.P., et al. Primary low-grade B-cell lymphoma of the dura: A mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol 21 (1997) 81-87
6. Kambham N., Chang Y., and Matsushima A.Y. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura. Clin Neuropathol 17 (1998) 311-317
7. Altundag M.K., Ozisik Y., Yalcin S., et al. Primary low grade B-cell lymphoma of the dura in an immunocompetent patient. J Exp Clin Cancer Res 19 (2000) 249-251
8. Sanjeevi A., Krishnan J., Bailey P.R., et al. Extranodal marginal zone B-cell lymphoma of malt type involving the cavernous sinus. Leuk Lymphoma 42 (2001) 1133-1137
9. Lehman N.L., Horoupian D.S., Warnke R.A., et al. Dural marginal zone lymphoma with massive amyloid deposition: Rare low-grade primary central nervous system B-cell lymphoma-Case report. J Neurosurg 96 (2002) 368-372
10. Goetz P., Lafuente J., Revesz T., et al. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma: Case report and review of the literature. J Neurosurg 96 (2002) 611-614
11. Vazquez A., Portillo E., Guridi J., et al. [Primary low-grade non-Hodgkin's B lymphoma mimicking meningioma]. Neurochir (Astur) 13 (2002) 50-53
12. Benouaich A., Delord J.P., Danjou M., et al. [Primary dural lymphoma: A report of two cases with review of the literature]. Rev Neurol (Paris) 159 (2003) 652-658
13. Bodi I., Hussain A., Gullan R.W., et al. January 2003: 56-year-old female with right frontal tumor of the dura. Brain Pathol 13 (2003) 417-423
14. Abboud H., Carpentier A., Martin-Duverneuil N., et al. MALT lymphoma presenting as a meningioma. J Neurooncol 75 (2005) 221
15. George A.C., Ozsahin M., Janzer R., et al. Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: Report of one case and review of the literature. Bull Cancer 92 (2005) E51-E56
16. Tu P.H., Giannini C., Judkins A.R., et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: A primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol 23 (2005) 5718-5727
17. Saggioro F.P., Colli B.O., Paixao-Becker A.N., et al. Primary low-grade MALT lymphoma of the dura. Histopathology 49 (2006) 323-326
18. Iwamoto F.M., DeAngelis L.M., and Abrey L.E. Primary dural lymphomas: A clinicopathologic study of treatment and outcome in eight patients. Neurology 66 (2006) 1763-1765
19. Pavlou G., Pal D., Bucur A., et al. Intracranial Non-Hodgkin's MALT lymphoma mimicking a large convexity meningioma. Acta Neurochir 148 (2006) 791-793
20. Isaacson P., and Wright D.H. Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B-cell lymphoma. Cancer 52 (1983) 1410-1416
21. Schechter N.R., Portlock C.S., and Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 16 (1998) 1916-1921
22. Schechter N.R., and Yahalom J. Low-grade MALT lymphoma of the stomach: A review of treatment options. Int J Radiat Oncol Biol Phys 46 (2000) 1093-1103
23. Tsang R.W., Gospodarowicz M.K., Pintilie M., et al. Stage I and II MALT lymphoma: Results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 1258-1264
24. DeAngelis L.M., Yahalom J., Thaler H.T., et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10 (1992) 635-643
25. Miller D.C., Hochberg F.H., Harris N.L., et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma: The Massachusetts General Hospital experience 1958-1989. Cancer 74 (1994) 1383-1397
26. Krogh-Jensen M., d'Amore F., Jensen M.K., et al., Danish Lymphoma Study Group, LYFO. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas: Population-based data from a Danish lymphoma registry. Ann Oncol 5 (1994) 349-354
27. Krogh-Jensen M., D'Amore F., Jensen M.K., et al. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: Trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area-Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma 19 (1995) 223-233
28. Lai R., Rosenblum M.K., and DeAngelis L.M. Primary CNS lymphoma: A whole-brain disease?. Neurology 59 (2002) 1557-1562
29. Yahalom J., Shah G.D., Lai R.K., et al. Reduced-dose whole brain radiotherapy (WBRT) following complete response to immuno-chemotherapy in patients with primary CNS lymphoma (PCNSL). [Abstract]. Int J Radiat Oncol Biol Phys 66 Suppl. (2006) S84
30. Fisher B., Seiferheld W., Schultz C., et al. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neurooncol 74 (2005) 201-205
31. Iwamoto F.M., and Abrey L.E. Primary dural lymphomas: A review. Neurosurg Focus 21 (2006) E5
32. Zucca E., Conconi A., Pedrinis E., et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101 (2003) 2489-2495
33. Thieblemont C., Bastion Y., Berger F., et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: Analysis of 108 patients. J Clin Oncol 15 (1997) 1624-1630
34. Thieblemont C., Berger F., Dumontet C., et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95 (2000) 802-806
35. Abrey L.E., DeAngelis L.M., and Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 16 (1998) 859-863
36. Abrey L.E., Yahalom J., and DeAngelis L.M. Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18 (2000) 3144-3150
37. Martinelli G., Laszlo D., Ferreri A.J., et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 23 (2005) 1979-1983
38. DeAngelis L.M., Mandell L.R., Thaler H.T., et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24 (1989) 798-805
39. Narayana A., Chang J., Thakur S., et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 80 (2007) 347-354
40. Chang J., Thakur S., Perera G., et al. Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys 33 (2006) 32-40
41. Narayana A., Yamada J., Berry S., et al. Intensity-modulated radiotherapy in high-grade gliomas: Clinical and dosimetric results. Int J Radiat Oncol Biol Phys 64 (2006) 892-897
42. Hermanto U., Frija E.K., Lii M.J., et al. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: Does IMRT increase the integral dose to normal brain?. Int J Radiat Oncol Biol Phys 67 (2007) 1135-1144
43. Assaf C., Coupland S.E., Hummel M., et al. Relapse of primary extranodal marginal-zone B-cell lymphoma of the dura mater. Lancet Oncol 6 (2005) 187-189